Biological role and prognostic significance of NAC1 in ovarian cancer

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 469-478

  Nakayama, Kentaro ^a   Rahman, Mohammed Tanjimur ^a   Rahman, Munmun ^a   Yeasmin, Shamima ^a   Ishikawa, Masako ^a   Katagiri, Atsuko ^a   Iida, Kouji ^a   Nakayama, Naomi ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

NAC1; Ovarian cancer; Survival

Indexed keywords

CARBOPLATIN; DOCETAXEL; LIPOFECTAMINE; NAC1 PROTEIN; PACLITAXEL; PROTEIN; RETROVIRUS VECTOR; RNA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DRUG TARGETING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RETROVIRUS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 78149362411     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.031     Document Type: Article

References (32)

1. P.A. Wingo, T. Tong, and S. Bolden Cancer statistics, 1995 CA Cancer J Clin 45 1995 8 30
2. M. Shih Ie, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 2004 1511 1518
3. M. Shih Ie, J.J. Sheu, A. Santillan, K. Nakayama, M.J. Yen, and R.E. Bristow Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma Proc Natl Acad Sci U S A 102 2005 14004 14009
4. J.T. Park, M. Li, K. Nakayama, T.L. Mao, B. Davidson, and Z. Zhang Notch3 gene amplification in ovarian cancer Cancer Res 66 2006 6312 6318
5. K. Nakayama, N. Nakayama, R.J. Kurman, L. Cope, G. Pohl, and Y. Samuels Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms Cancer Biol Ther 5 2006 779 785
6. K. Nakayama, N. Nakayama, N. Jinawath, R. Salani, R.J. Kurman, and M. Shih Ie Amplicon profiles in ovarian serous carcinomas Int J Cancer 120 2007 2613 2617
7. R. Agarwal, M. Linch, and S.B. Kaye Novel therapeutic agents in ovarian cancer Eur J Surg Oncol 32 2006 875 886
8. P.J. Stogios, G.S. Downs, J.J. Jauhal, S.K. Nandra, and G.G. Prive Sequence and structural analysis of BTB domain proteins Genome Biol 6 2005 R82
9. K. Nakayama, N. Nakayama, B. Davidson, J.J. Sheu, N. Jinawath, and A. Santillan A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival Proc Natl Acad Sci U S A 103 2006 18739 18744
10. J. Wang, S. Rao, J. Chu, X. Shen, D.N. Levasseur, and T.W. Theunissen A protein interaction network for pluripotency of embryonic stem cells Nature 444 2006 364 368
11. S. Yeasmin, K. Nakayama, M. Ishibashi, A. Katagiri, K. Iida, and I.N. Purwana Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis Clin Cancer Res 14 2008 1686 1691
12. M. Ishibashi, K. Nakayama, S. Yeasmin, A. Katagiri, K. Iida, and N. Nakayama A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer Clin Cancer Res 14 2008 3149 3155
13. N. Jinawath, C. Vasoontara, K.L. Yap, M.M. Thiaville, K. Nakayama, and T.L. Wang NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway Oncogene 28 2009 1941 1948
14. K. Yamamoto, Y. Kikuchi, K. Kudoh, and I. Nagata Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines J Cancer Res Clin Oncol 126 2000 168 172
15. K. Nakayama, K. Miyazaki, A. Kanzaki, M. Fukumoto, and Y. Takebayashi Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines Oncol Rep 8 2001 1285 1287
16. Anon. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition) Br J Cancer 77 1998 1 10
17. M. Shih Ie, and R.J. Kurman Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges Clin Cancer Res 11 2005 7273 7279
18. D.R. Schwartz, S.L. Kardia, K.A. Shedden, R. Kuick, G. Michailidis, and J.M. Taylor Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res 62 2002 4722 4729
19. R.T. Marquez, K.A. Baggerly, A.P. Patterson, J. Liu, R. Broaddus, and M. Frumovitz Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon Clin Cancer Res 11 2005 6116 6126
20. M. Scott, and P.A. Hall Prognostic and predictive factors Methods Mol Med 97 2004 1 11
21. T.P. Diaz-Montes, and R.E. Bristow Secondary cytoreduction for patients with recurrent ovarian cancer Curr Oncol Rep 7 2005 451 458
22. P. Harter, and A. du Bois The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence Curr Opin Oncol 17 2005 505 514
23. A. Gadducci, P. Iacconi, S. Cosio, A. Fanucchi, R. Cristofani, and A. Riccardo Genazzani Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer Gynecol Oncol 79 2000 344 349
24. A. Gadducci, P. Iacconi, A. Fanucchi, S. Cosio, G. Teti, and A.R. Genazzani Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer Anticancer Res 20 2000 1959 1964
25. R.Y. Zang, Z.T. Li, J. Tang, X. Cheng, S.M. Cai, and Z.Y. Zhang Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 100 2004 1152 1161
26. J. Kim, J. Chu, X. Shen, J. Wang, and S.H. Orkin An extended transcriptional network for pluripotency of embryonic stem cells Cell 132 2008 1049 1061
27. I.B. Weinstein, and A. Joe Oncogene addiction Cancer Res 68 2008 3077 3080 [discussion 3080]
28. X.Y. Cha, R.C. Pierce, P.W. Kalivas, and S.A. Mackler NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration J Neurosci 17 1997 6864 6871
29. L. Korutla, P.J. Wang, and S.A. Mackler The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures J Neurochem 94 2005 786 793
30. A. Hayashi, A. Horiuchi, N. Kikuchi, T. Hayashi, C. Fuseya, and A. Suzuki Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin Int J Cancer 127 2010 1332 1346
31. R.J. Kurman, and M. Shih Ie Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 2008 151 160
32. K.R. Cho, and M. Shih Ie Ovarian cancer Annu Rev Pathol 4 2009 287 313